Literature DB >> 24695064

Fluorescein angiography versus optical coherence tomography-guided planning for macular laser photocoagulation in diabetic macular edema.

Igor Kozak1, Sharif Y El-Emam, Lingyun Cheng, Dirk-Uwe Bartsch, Jay Chhablani, William R Freeman, J Fernando Arevalo.   

Abstract

PURPOSE: To compare laser photocoagulation plans for diabetic macular edema (DME) using fluorescein angiography (FA) versus optical coherence tomography (OCT) thickness map superimposed on the retina.
METHODS: Fourteen eyes with DME undergoing navigated laser photocoagulation with navigated photocoagulator had FA taken using the same instrument. Optical coherence tomography central retinal thickness map was imported to the photocoagulator and with same magnification aligned onto the retina. Three retina specialists placed laser spot marks separately on FA and OCT image in a masked fashion. The spots placed by each physician were compared between FA and OCT and among physicians. The area of dye leakage on FA and increased central retinal thickness on OCT of the same eye were also compared.
RESULTS: The average number of spots using FA and OCT template was 36.64 and 40.61, respectively (P = 0.0201). The average area of dye leakage was 7.45 mm, whereas the average area of increased central retinal thickness on OCT of the same eye was 10.92 mm (P = 0.013).
CONCLUSION: There is variability in the treatment planning for macular photocoagulation with a tendency to place more spots when guided by OCT than by FA. Integration of OCT map aligned to the retina may have an impact on treatment plan once such information is available.

Entities:  

Mesh:

Year:  2014        PMID: 24695064      PMCID: PMC4695978          DOI: 10.1097/IAE.0000000000000120

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  20 in total

1.  Qualitative and quantitative OCT response of diffuse diabetic macular oedema to macular laser photocoagulation.

Authors:  R Vemala; S Koshy; S Sivaprasad
Journal:  Eye (Lond)       Date:  2011-04-15       Impact factor: 3.775

2.  Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1987-07       Impact factor: 12.079

3.  The importance of fluorescein angiography in planning laser treatment of diabetic macular edema.

Authors:  J A Kylstra; J C Brown; G J Jaffe; T A Cox; R Gallemore; C M Greven; J G Hall; D E Eifrig
Journal:  Ophthalmology       Date:  1999-11       Impact factor: 12.079

4.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Authors:  Paul Mitchell; Francesco Bandello; Ursula Schmidt-Erfurth; Gabriele E Lang; Pascale Massin; Reinier O Schlingemann; Florian Sutter; Christian Simader; Gabriela Burian; Ortrud Gerstner; Andreas Weichselberger
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

5.  Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Neil M Bressler; Haijing Qin; Roy W Beck; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

6.  New insights into the pathoanatomy of diabetic macular edema: angiographic patterns and optical coherence tomography.

Authors:  Suk Ho Byeon; Young Kwang Chu; Young Taek Hong; Min Kim; Hae Min Kang; Oh Woong Kwon
Journal:  Retina       Date:  2012-06       Impact factor: 4.256

7.  Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography.

Authors:  Justin C Brown; Sharon D Solomon; Susan B Bressler; Andrew P Schachat; Cathy DiBernardo; Neil M Bressler
Journal:  Arch Ophthalmol       Date:  2004-03

8.  Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography.

Authors:  David J Browning; Michael D McOwen; Robert M Bowen; Tisha L O'Marah
Journal:  Ophthalmology       Date:  2004-04       Impact factor: 12.079

9.  Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema.

Authors:  Matthew D Davis; Susan B Bressler; Lloyd Paul Aiello; Neil M Bressler; David J Browning; Christina J Flaxel; Donald S Fong; William J Foster; Adam R Glassman; Mary Elizabeth R Hartnett; Craig Kollman; Helen K Li; Haijing Qin; Ingrid U Scott
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-03       Impact factor: 4.799

10.  Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser.

Authors:  Aljoscha S Neubauer; Julian Langer; Raffael Liegl; Christos Haritoglou; Armin Wolf; Igor Kozak; Florian Seidensticker; Michael Ulbig; William R Freeman; Anselm Kampik; Marcus Kernt
Journal:  Clin Ophthalmol       Date:  2013-01-16
View more
  10 in total

1.  Treatment decisions in diabetic macular edema based on optical coherence tomography retinal thickness map: LET classification.

Authors:  Rosa Dolz-Marco; Rodrigo Abreu-González; Marta Alonso-Plasencia; Roberto Gallego-Pinazo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-09       Impact factor: 3.117

Review 2.  Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019.

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

3.  Multi-label classification of retinal lesions in diabetic retinopathy for automatic analysis of fundus fluorescein angiography based on deep learning.

Authors:  Xiangji Pan; Kai Jin; Jing Cao; Zhifang Liu; Jian Wu; Kun You; Yifei Lu; Yufeng Xu; Zhaoan Su; Jiekai Jiang; Ke Yao; Juan Ye
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-14       Impact factor: 3.117

4.  Retro-Mode Scanning Laser Ophthalmoscopy Planning for Navigated Macular Laser Photocoagulation in Macular Edema.

Authors:  Ernest V Boiko; Dmitrii S Maltsev
Journal:  J Ophthalmol       Date:  2016-02-17       Impact factor: 1.909

5.  Combination of Navigated Macular Laser Photocoagulation and Anti-VEGF Therapy: Precise Treatment for Macular Edema under Dry Retinal Conditions.

Authors:  Ernest V Boiko; Dmitrii S Maltsev
Journal:  J Ophthalmol       Date:  2017-02-20       Impact factor: 1.909

6.  Direct navigated laser photocoagulation as primary treatment for retinal arterial macroaneurysms.

Authors:  Dmitrii S Maltsev; Alexei N Kulikov; Bhushan Uplanchiwar; Luiz H Lima; Jay Chhablani
Journal:  Int J Retina Vitreous       Date:  2018-08-22

7.  The quantitative measurements of choroidal thickness and volume in diabetic retinopathy using optical coherence tomography and optical coherence tomography angiography; correlation with vision and foveal avascular zone.

Authors:  Fariba Ghassemi; Sahar Berijani; Ameneh Babeli; Houshang Faghihi; Alireza Gholizadeh; Siamak Sabour
Journal:  BMC Ophthalmol       Date:  2022-01-03       Impact factor: 2.209

8.  Intraprocedural OCT monitoring of the immediate treatment response during indocyanine green angiography-guided laser therapy of teleangiectatic capillaries in diabetic macular edema.

Authors:  Felix Datlinger; Anja Datlinger; Andreas Pollreisz; Stefan Sacu; Ursula Schmidt-Erfurth; Peter Datlinger
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

9.  Bridging the resources gap: deep learning for fluorescein angiography and optical coherence tomography macular thickness map image translation.

Authors:  Hazem Abdelmotaal; Mohamed Sharaf; Wael Soliman; Ehab Wasfi; Salma M Kedwany
Journal:  BMC Ophthalmol       Date:  2022-09-01       Impact factor: 2.086

10.  Characteristics of diabetic macular edema patients with serous retinal detachment.

Authors:  Hyung Bin Hwang; Donghyun Jee; Jin-Woo Kwon
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.